Sagimet Biosciences, Inc. Class A (SGMT) has released an update to notify the public and investors about its officers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sagimet Biosciences Inc. announced that following the resignation of their CFO Anthony Rimac, the board appointed Joseph Oriti as the Interim Principal Financial Officer and Interim Principal Accounting Officer, starting February 1, 2024. Oriti, a director at Stout Risius Ross, LLC, brings extensive experience to the role, having previously held director positions at Riveron and SOLIC Capital. His appointment is not the result of any pre-arranged agreements, and he has no familial ties to the company’s directors or executive officers.
For further insights into SGMT corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.